Vaccine Development for Group A Streptococcus Infections and Associated Diseases

E-ISSN： 1873-5592|5|1|57-69

ISSN： 1389-4501

Source： Current Drug Targets, Vol.5, Iss.1, 2004-01, pp. : 57-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates Against Group A Streptococcus

Medicinal Chemistry, Vol. 13, Iss. 1, 2016-12 ,pp. : 22-27

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in Development of Group A Streptococcus Vaccines

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 11, 2013-11 ,pp. : 947-950

Bentham Science Publishers

Access to resources Recommend Favorite

Knowing is Half the Battle: Targeting Virulence Factors of Group A Streptococcus for Vaccine and Therapeutics

Current Drug Targets, Vol. 13, Iss. 3, 2012-03 ,pp. : 308-322

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccine Therapy for P. acnes-Associated Diseases

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 8, Iss. 3, 2008-09 ,pp. : 160-165

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Conformational Mimetics of Conserved Streptococcus Pyogenes Minimal Epitope as Vaccine Candidates

Current Drug Delivery, Vol. 6, Iss. 5, 2009-10 ,pp. : 520-527

Bentham Science Publishers

Access to resources Recommend Favorite